The MyD88+ phenotype is an adverse prognostic factor in epithelial ovarian cancer. [electronic resource]
Producer: 20150219Description: e100816 p. digitalISSN:- 1932-6203
- Aged
- Antineoplastic Agents, Phytogenic -- pharmacology
- Carcinoma, Ovarian Epithelial
- Cell Line, Tumor
- Cystadenocarcinoma, Serous -- diagnosis
- Drug Resistance, Neoplasm -- genetics
- Female
- Gene Expression Regulation, Neoplastic
- Genotype
- Humans
- Immunohistochemistry
- MicroRNAs -- genetics
- Middle Aged
- Myeloid Differentiation Factor 88 -- genetics
- Neoplasms, Glandular and Epithelial -- diagnosis
- Neoplastic Stem Cells -- drug effects
- Ovarian Neoplasms -- diagnosis
- Paclitaxel -- pharmacology
- Phenotype
- Prognosis
- RNA, Small Interfering -- genetics
- Signal Transduction
- Survival Analysis
- Toll-Like Receptor 4 -- antagonists & inhibitors
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.